TRENTON, N.J., Dec. 08, 2016 -- In response to the proposed surgical declawing ban now before the New Jersey Assembly (A3899) and the Senate (S2410), the New Jersey Veterinary Medical Association (NJVMA) launched a public campaign at LoveYourCats.org opposing the increased euthanasia that would certainly result from a surgical declawing ban.
Surgical declawing with advanced pain control methods is recommended by doctors as a last resort, as an alternative to euthanasia or abandonment.
“We want to see cats in loving, caring households,” says Dr. Michael Yurkus of the NJVMA. “We know that 72% of all cats sent to shelters will be euthanized, and this is a 100% preventable tragedy. As the leading advocates for saving the lives of unwanted or discarded animals, we’re laying out the vital facts and calling on concerned citizens to oppose this legislation at LoveYourCats.org.”
While veterinarians have reduced declawing through better education regarding the alternatives, the NJVMA is especially concerned for cats living with people taking immunity suppressing medication or blood thinners, or people with blood disorders, where an animal scratch would pose a health risk. Also of concern are the cats living with the elderly in facilities that require cats to be declawed.
About the New Jersey Veterinary Medical Association (NJVMA)
Founded in 1884 as a professional association representing the state’s 1,600 licensed veterinarians, the NJVMA is dedicated to advancing the veterinary profession in New Jersey, protecting the health of animals and extending progressive leadership in the research, care, treatment, and welfare of animals. The NJVMA encourages high ethical standards and competence in the treatment of animals and promotes excellence in the professional training and continuing education of doctors of veterinary medicine. The association is a nexus point for all the issues, factors, and organizations that will have an impact on New Jersey’s veterinarians. For more information, go to www.njvma.org
Contact Karen Geisel at (518) 421-3435


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 



